Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for recovery in mentally disabled adults undergoing dental treatment under general anesthesia
IRCT20190626044013N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in intellectual disability (ID) comparing Dexmedetomidine intervention with Propofol control (2 arms). Primary endpoints: systolic blood pressure, heart rate and 4 more. Started Apr 2021; status: completed.
02
Drugs
dexmedetomidinepropofol
03
Conditions
intellectual disability (ID)
Beyond the preview
Go deeper on IRCT20190626044013N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190626044013N2.